Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir

Dr. Shailendranath Biswas
Dr. Shailendranath Biswas
Dr. S K Ballav
Dr. S K Ballav
Dr. Sheikh Farid Uddin Ahmed
Dr. Sheikh Farid Uddin Ahmed
Dr. Utpal Kumar Chanda
Dr. Utpal Kumar Chanda
Dr.Tahmida Khanom
Dr.Tahmida Khanom
Dr. Mohaiminul Haque
Dr. Mohaiminul Haque
Dr. Ripon Roy
Dr. Ripon Roy
Dr. Avijit Kumar Mridha
Dr. Avijit Kumar Mridha
Khulna Medical University

Send Message

To: Author

Outcome Assessment in Case of Severe COVID-19  Patients Treated with Remdesivir

Article Fingerprint

ReserarchID

OSD9X

Outcome Assessment in Case of Severe COVID-19  Patients Treated with Remdesivir Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

References

17 Cites in Article
  1. Stanley Perlman (2020). Another Decade, Another Coronavirus.
  2. Yosra Helmy,Mohamed Fawzy,Ahmed Elaswad,Ahmed Sobieh,Scott Kenney,Awad Shehata (2020). The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control.
  3. Moira Chan‐yeung,Rui‐heng Xu (2003). SARS: epidemiology.
  4. Shashank Joshi,Jalil Parkar,Abdul Ansari,Agam Vora,Deepak Talwar,Mangesh Tiwaskar,Saiprasad Patil,Hanmant Barkate (2020). Role of favipiravir in the treatment of COVID-19.
  5. A Pg (2020). Coronavirus COVID-19 (SARS-CoV-2).
  6. V Yan,F Muller (2020). Metropole de Lyon unveils the 14 winners of its Appel des 30.
  7. Timothy Sheahan,Amy Sims,Sarah Leist,Alexandra Schäfer,John Won,Ariane Brown,Stephanie Montgomery,Alison Hogg,Darius Babusis,Michael Clarke,Jamie Spahn,Laura Bauer,Scott Sellers,Danielle Porter,Joy Feng,Tomas Cihlar,Robert Jordan,Mark Denison,Ralph Baric (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
  8. Maria Agostini,Erica Andres,Amy Sims,Rachel Graham,Timothy Sheahan,Xiaotao Lu,Everett Smith,James Case,Joy Feng,Robert Jordan,Adrian Ray,Tomas Cihlar,Dustin Siegel,Richard Mackman,Michael Clarke,Ralph Baric,Mark Denison (2018). Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
  9. Manli Wang,Ruiyuan Cao,Leike Zhang,Xinglou Yang,Jia Liu,Mingyue Xu,Zhengli Shi,Zhihong Hu,Wu Zhong,Gengfu Xiao (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
  10. Emmie De Wit,Friederike Feldmann,Jacqueline Cronin,Robert Jordan,Atsushi Okumura,Tina Thomas,Dana Scott,Tomas Cihlar,Heinz Feldmann (2020). Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
  11. Who (2020). COVID-19 statistical report - 18 November 2020.
  12. F Lamontagne (2020). A living WHO guideline on drugs for covid-19.
  13. Dghs (2020). More US COVID-19 aid may pass by November.
  14. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
  15. John Beigel,Kay Tomashek,Lori Dodd,Aneesh Mehta,Barry Zingman,Andre Kalil,Elizabeth Hohmann,Helen Chu,Annie Luetkemeyer,Susan Kline,Diego Lopez De Castilla,Robert Finberg,Kerry Dierberg,Victor Tapson,Lanny Hsieh,Thomas Patterson,Roger Paredes,Daniel Sweeney,William Short,Giota Touloumi,David Lye,Norio Ohmagari,Myoung-Don Oh,Guillermo Ruiz-Palacios,Thomas Benfield,Gerd Fätkenheuer,Mark Kortepeter,Robert Atmar,C Creech,Jens Lundgren,Abdel Babiker,Sarah Pett,James Neaton,Timothy Burgess,Tyler Bonnett,Michelle Green,Mat Makowski,Anu Osinusi,Seema Nayak,H Lane (2020). Remdesivir for the Treatment of Covid-19 — Final Report.
  16. Yeming Wang,Dingyu Zhang,Guanhua Du,Ronghui Du,Jianping Zhao,Yang Jin,Shouzhi Fu,Ling Gao,Zhenshun Cheng,Qiaofa Lu,Yi Hu,Guangwei Luo,Ke Wang,Yang Lu,Huadong Li,Shuzhen Wang,Shunan Ruan,Chengqing Yang,Chunlin Mei,Yi Wang,Dan Ding,Feng Wu,Xin Tang,Xianzhi Ye,Yingchun Ye,Bing Liu,Jie Yang,Wen Yin,Aili Wang,Guohui Fan,Fei Zhou,Zhibo Liu,Xiaoying Gu,Jiuyang Xu,Lianhan Shang,Yi Zhang,Lianjun Cao,Tingting Guo,Yan Wan,Hong Qin,Yushen Jiang,Thomas Jaki,Frederick Hayden,Peter Horby,Bin Cao,Chen Wang (2020). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
  17. Christoph Spinner,Robert Gottlieb,Gerard Criner,José Arribas López,Anna Cattelan,Alex Soriano Viladomiu,Onyema Ogbuagu,Prashant Malhotra,Kathleen Mullane,Antonella Castagna,Louis Chai,Meta Roestenberg,Owen Tsang,Enos Bernasconi,Paul Le Turnier,Shan-Chwen Chang,Devi Sengupta,Robert Hyland,Anu Osinusi,Huyen Cao,Christiana Blair,Hongyuan Wang,Anuj Gaggar,Diana Brainard,Mark Mcphail,Sanjay Bhagani,Mi Ahn,Arun Sanyal,Gregory Huhn,Francisco Marty (2020). Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Shailendranath Biswas. 2021. \u201cOutcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir\u201d. Global Journal of Medical Research - K: Interdisciplinary GJMR-K Volume 21 (GJMR Volume 21 Issue K7).

Download Citation

High-quality alternative medicine research journal.
Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-K Classification NLMC Code: WB 115
Version of record

v1.2

Issue date
November 10, 2021

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 1904
Total Downloads: 878
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir

Dr. Shailendranath Biswas
Dr. Shailendranath Biswas
Dr. S K Ballav
Dr. S K Ballav
Dr. Sheikh Farid Uddin Ahmed
Dr. Sheikh Farid Uddin Ahmed
Dr. Utpal Kumar Chanda
Dr. Utpal Kumar Chanda
Dr.Tahmida Khanom
Dr.Tahmida Khanom
Dr. Mohaiminul Haque
Dr. Mohaiminul Haque
Dr. Ripon Roy
Dr. Ripon Roy
Dr. Avijit Kumar Mridha
Dr. Avijit Kumar Mridha

Research Journals